iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation's Largest Radiology PracticeGlobeNewsWire • 07/18/23
iCAD's “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland ClinicGlobeNewsWire • 07/12/23
iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual MeetingGlobeNewsWire • 07/10/23
iCAD's ProFound AI Breast Suite Wins U.S. General Services Administration's AI Healthcare Challenge AwardGlobeNewsWire • 05/18/23
ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk AssessmentsGlobeNewsWire • 04/04/23
iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year EndGlobeNewsWire • 03/28/23
iCAD's Breast AI Suite Empowers Customers to Lead the Way in Support of FDA's National Breast Density Reporting StandardGlobeNewsWire • 03/23/23
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023GlobeNewsWire • 03/13/23
New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists' Efficiency and AccuracyGlobeNewsWire • 03/01/23